2022
DOI: 10.1016/s2352-3026(22)00207-1
|View full text |Cite
|
Sign up to set email alerts
|

Packed red blood cell transfusion in preterm infants

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 67 publications
0
2
0
Order By: Relevance
“…The development of NEC also involves some other common clinical risk factors, such as severe anemia and blood transfusion exposure, and the exploration of its pathogenesis has confirmed the importance of IMφs. Evidence supports the association between RBC transfusion and adverse clinical outcomes, such as NEC, after anemia in preterm infants ( 90 ). However, there is no consensus on whether transfusion-related intestinal injury is caused by severe anemia or RBC transfusion ( 91 , 92 ), which was recently investigated using a neonatal murine model of transfusion-associated NEC.…”
Section: Role Of Imφs In Pathogenesis Of Necmentioning
confidence: 90%
“…The development of NEC also involves some other common clinical risk factors, such as severe anemia and blood transfusion exposure, and the exploration of its pathogenesis has confirmed the importance of IMφs. Evidence supports the association between RBC transfusion and adverse clinical outcomes, such as NEC, after anemia in preterm infants ( 90 ). However, there is no consensus on whether transfusion-related intestinal injury is caused by severe anemia or RBC transfusion ( 91 , 92 ), which was recently investigated using a neonatal murine model of transfusion-associated NEC.…”
Section: Role Of Imφs In Pathogenesis Of Necmentioning
confidence: 90%
“…The etiologies of NEC encompass formula feeding, hypoxia, infection 1 . However, the debate over whether red blood cell (RBC) transfusion is associated with NEC in preterm infants continues to be widely discussed 2 .…”
Section: Introductionmentioning
confidence: 99%
“…Interestingly, U-RBC use has been associated with a lower likelihood of developing transfusion-related comorbidities, since its physiological features are closer to a newborn's physiology [3][4][5]. U-RBCs have specific biological features capable of promoting better patient outcomes than those observed for adult RBCs (A-RBCs), namely, bigger erythrocyte size, high foetal haemoglobin concentrations, growth factors (GFs) and cytokine incidence and immunologic cells' performance, among other features, observed between these two blood donor types [6,7]. Using U-RBCs in LBW and ELBW pre-term neonates can help mitigate severe anaemia without depleting foetal haemoglobin since it often takes place after A-RBC transfusions [4].…”
Section: Introductionmentioning
confidence: 99%